2020
Elevated circulating CCL2 in prostate cancer patients.
Lin J, Caress A, Ahmed F, Taylor N, Gong Y, Oh W. Elevated circulating CCL2 in prostate cancer patients. Journal Of Clinical Oncology 2020, 38: 201-201. DOI: 10.1200/jco.2020.38.6_suppl.201.Peer-Reviewed Original ResearchProstate cancer patientsProstate cancerProstate cancer cellsCCL2 concentrationsHuman cytokine arrayElevated CCL2Tumor microenvironmentCytokine arrayCCL2 mRNACCL2 inductionPC3 cellsPatient seraPC3 PCa cell linesConditioned mediumIL-6Prostate cancer patient seraImmunosuppressive tumor microenvironmentMonocyte chemoattractant protein-1Secretion of CCL2GM-CSF-dependent mannerPCa cell linesChemoattractant protein-1Cancer patient seraControl patient serumIn vitro coculture model
2011
PC3 is a cell line characteristic of prostatic small cell carcinoma
Tai S, Sun Y, Squires J, Zhang H, Oh W, Liang C, Huang J. PC3 is a cell line characteristic of prostatic small cell carcinoma. The Prostate 2011, 71: 1668-1679. PMID: 21432867, PMCID: PMC3426349, DOI: 10.1002/pros.21383.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaAnimalsBlotting, WesternCarcinoma, NeuroendocrineCarcinoma, Small CellCell Line, TumorHumansImmunohistochemistryMaleMiceMice, SCIDNeoplasm TransplantationNeoplasms, Hormone-DependentProstate-Specific AntigenProstatic NeoplasmsReceptors, AndrogenReverse Transcriptase Polymerase Chain ReactionRNA, NeoplasmTransplantation, HeterologousConceptsSmall cell neuroendocrine carcinomaProstate-specific antigenHuman prostate adenocarcinomaLNCaP cellsAndrogen receptorProstatic adenocarcinomaProstate cancerPC3 cellsHormone therapyProstatic small cell neuroendocrine carcinomaProstatic small cell carcinomaInhibit AR signalingCell neuroendocrine carcinomaSmall cell carcinomaPC cell linesAndrogen withdrawalMetastatic adenocarcinomaNeuroendocrine carcinomaCell carcinomaNeuroendocrine markersAndrogen-dependentAR signalingWestern blot analysisGlandular formationTumor cells
2007
Doxazosin-induced clusterin expression and apoptosis in prostate cancer cells
Youm YH, Yang H, Yoon YD, Kim DY, Lee C, Yoo TK. Doxazosin-induced clusterin expression and apoptosis in prostate cancer cells. Urologic Oncology Seminars And Original Investigations 2007, 25: 483-488. PMID: 18047956, DOI: 10.1016/j.urolonc.2007.02.010.Peer-Reviewed Original ResearchConceptsProstate cancer cellsAndrogen-independent human prostate cancer cellsCancer cellsHuman prostate cancer cellsTranscriptase-polymerase chain reactionNick-end labeling assayMicroM doxazosinDegree of apoptosisDNA fragmentationDoxazosin treatmentClusterin mRNA expressionPolymerase chain reactionDoxazosin-induced apoptosisClusterin expressionMRNA expressionPC3 cellsPresence of clusterinClusterin mRNAChain reactionClusterinApoptotic cellsLabeling assaysDoxazosinApoptosis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply